论文信息 - Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors - 字舞流文

Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors

E. Schmidt | A. Tolcher | M. Sznol | S. Hu-Lieskovan | K. Papadopoulos | D. Rasco | A. Patnaik | N. Pathan | A. Thall | L. Chow | Donna Di Gravio | Bo Huang | Dhiraj Gambhire | Ying Chen | B. Huang | D. Gambhire